Exodus Point Capital Management, LP Bio Xcel Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$11.19 - $17.89 $298,012 - $476,446	-26,632 Closed	0 $0
Q2 2022 Aug 19, 2022	BUY	$9.03 - $21.55 $240,486 - $573,919	26,632 New	26,632 $352,000
Q1 2022 May 13, 2022	SELL	$15.0 - $22.83 $157,470 - $239,669	-10,498 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$20.12 - $35.09 $211,219 - $368,374	10,498 New	10,498 $213,000
Q4 2020 Feb 16, 2021	SELL	$42.46 - $56.58 $248,178 - $330,710	-5,845 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$37.44 - $64.63 $218,836 - $377,762	5,845 New	5,845 $253,000

3.13M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.53M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.